MHRA approves Pfizer/BioNTech’s adapted COVID-19 vaccine for Omicron XBB.1.5
The vaccine has been approved for use in individuals from six months of age
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Covid 19 vaccine
Biden administration to urge Americans get COVID-19 boosters
The official said that while the Centers for Disease Control and Prevention are reporting an increase in infections and hospital…
SII restarts manufacturing of COVISHIELD
Adar Poonawalla informs that the company already has six million booster doses of Covovax vaccine available and adults must take…
Stability of input costs, specialty product launches to support performance of Indian pharma…
Revenues of ICRA’s sample set expected to grow by 6-8 per cent in FY2023 and FY2024; operating profit margins to stabilise at…
Pfizer agrees to revise COVID vaccine contract with EU: Reports
Under the revised terms, Pfizer is asking for payment for doses ordered that will never be manufactured
GlobalData upgrades Pfizer’s COVID-19 vaccine sales forecast to $37 bn in 2022
In 2023, Comirnaty is expected to have an even better year, with sales forecasts up by 16 per cent
BioNTech sees UK trials on cancer vaccines starting this year: Ugur Sahin
The company wants these therapies, which are based on mRNA technology similar to the one that underpins its COVID-19 vaccine, to…
US govt to procure 1.5 million more doses of Novavax COVID-19 vaccine
The protein-based vaccine was expected to convince those sceptical of the new mRNA-based vaccines against the virus from rivals…
Health minister unveils India’s first intra-nasal COVID vaccine
iNNCOVACC is the world’s first intra-nasal COVID-19 vaccine to receive approval for the primary two-dose schedule, and as a…
First made-in-India intra-nasal COVID vaccine to be launched on R-Day
The nasal vaccine can be taken after six months of the second dose